Psilocybin: From Counterculture Menace to Potential Treatment for Depression

Psilocybin has gained recent media attention for its potential as a therapeutic in the treatment of Major Depressive Disorder. Just this month, a Canadian pharmaceuticals company, Cybin, received approval to conduct Phase II of its psilocybin formulation, named CYB001. What is Psilocybin? Psilocybin is a compound found in some 200 species of fungi. Upon ingestion,…

Read More